Dhamyaa
Dhamyaa, licence 80067790: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Devang Holdings Private Limited
- NPN or DIN-HM
- 80067790
- Status
- Active licence
- Licence date
- 17 March 2016
- Revision date
- 30 March 2016
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Terminalia arjuna Source : Écorce (tige) | 0.5 g | Not calculated |
| Commiphora wightii Source : Gum oleoresin | 0.25 g | Not calculated |
| Allium sativum Source : Bulbe | 0.25 g | Not calculated |
| Cinnamomum tamala Source : Feuille | 0.1 g | Not calculated |
| Linum usitatissimum Source : Graine(s) | 0.25 g | Not calculated |
| Eclipta prostrata Source : Plante entière | 0.25 g | Not calculated |
| Tinospora cordifolia Source : Tige | 0.25 g | Not calculated |
| Glycyrrhiza glabra Source : Racine | 0.2 g | Not calculated |
| Glycyrrhiza glabra Source : Tige | 0.2 g | Not calculated |
| Curcuma longa Source : Rhizome | 0.05 g | Not calculated |
| Tribulus terrestris Source : Fruit | 0.2 g | Not calculated |
| Azadirachta indica Source : Feuille | 0.2 g | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Mesures | 2.0 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help reduce elevated blood lipid levels/hyperlipidaemia in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity such as allergy has been known to occur in rare cases; in which case, discontinue use. May cause temporary gas and bloating. Diuretic effect may occur. Discontinue use if gastrointestinal discomfort, headache and/or skin rash appear. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing and/or irregular bleeding (due to presence of multiple diuretics and Licorice).
- Précautions et mises en garde
Please consult your healthcare practitioner before using Dhamyaa. If you are taking prescription medications and/or if you have any serious medicinal condition, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80067790
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.